Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OFIX Orthofix Medical Inc
- Stocks
- Healthcare
- NASDAQ: OFIX
Price (delayed)
$10.97
Market cap
$429.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.69
Enterprise value
$544.65M
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with
Highlights
Orthofix Medical's quick ratio has increased by 29% YoY
The gross profit has increased by 7% year-on-year
Orthofix Medical's debt has increased by 28% YoY
The equity has contracted by 20% YoY and by 9% from the previous quarter
Key stats
What are the main financial stats of OFIX
Market
Valuations
Earnings
Shares outstanding
39.18M
Market cap
$429.81M
Enterprise value
$544.65M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.93
Price to sales (P/S)
0.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.68
Revenue
$804.53M
Gross profit
$540.26M
Operating income
-$104.16M
Net income
-$143.07M
EBIT
-$111.26M
EBITDA
-$31.63M
Free cash flow
-$4.8M
Per share
Balance sheet
Liquidity
EPS
-$3.69
EPS diluted
-$3.69
Free cash flow per share
-$0.12
Book value per share
$11.74
Revenue per share
$20.53
TBVPS
$13.96
Total assets
$823.14M
Total liabilities
$364.85M
Debt
$175.29M
Equity
$458.29M
Working capital
$246.19M
Debt to equity
0.38
Current ratio
2.71
Quick ratio
1.33
Net debt/EBITDA
-3.63
Margins
Efficiency
Dividend
EBITDA margin
-3.9%
Gross margin
67.2%
Net margin
-17.8%
Operating margin
-12.9%
Return on assets
-16.5%
Return on equity
-28.1%
Return on invested capital
-21.4%
Return on capital employed
-16.4%
Return on sales
-13.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OFIX stock price
How has the Orthofix Medical stock price performed over time
Intraday
1.57%
1 week
4.28%
1 month
-1.17%
1 year
-15.68%
YTD
-37.17%
QTD
-32.74%
Financial performance
How have Orthofix Medical's revenue and profit performed over time
Revenue
$804.53M
Gross profit
$540.26M
Operating income
-$104.16M
Net income
-$143.07M
Gross margin
67.2%
Net margin
-17.8%
The company's operating income fell by 23% QoQ but it rose by 4.2% YoY
The company's operating margin fell by 22% QoQ but it rose by 10% YoY
The net income has contracted by 14% from the previous quarter and by 13% YoY
Orthofix Medical's net margin has decreased by 13% from the previous quarter and by 7% YoY
Price vs fundamentals
How does OFIX's price correlate with its fundamentals
Growth
What is Orthofix Medical's growth rate over time
Valuation
What is Orthofix Medical stock price valuation
P/E
N/A
P/B
0.93
P/S
0.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.68
The EPS has contracted by 12% from the previous quarter and by 9% YoY
The stock's price to book (P/B) is 38% less than its 5-year quarterly average of 1.5 and 23% less than its last 4 quarters average of 1.2
The equity has contracted by 20% YoY and by 9% from the previous quarter
The price to sales (P/S) is 56% lower than the 5-year quarterly average of 1.2 and 34% lower than the last 4 quarters average of 0.8
The revenue is up by 6% year-on-year
Efficiency
How efficient is Orthofix Medical business performance
OFIX's ROE is down by 34% YoY and by 20% QoQ
The ROIC has contracted by 20% from the previous quarter
OFIX's return on assets is down by 19% year-on-year and by 16% since the previous quarter
The ROS has contracted by 17% from the previous quarter but it has grown by 6% YoY
Dividends
What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OFIX.
Financial health
How did Orthofix Medical financials performed over time
The total assets is 126% greater than the total liabilities
Orthofix Medical's quick ratio has increased by 29% YoY
The total assets has declined by 9% year-on-year and by 8% since the previous quarter
Orthofix Medical's debt is 62% less than its equity
OFIX's debt to equity has soared by 58% YoY and by 9% from the previous quarter
Orthofix Medical's debt has increased by 28% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.